Payment overview · 2025
General Payments
$250.00
2 reported records · 2 companies
Healthcare provider profile · identity verified
Derek Scott Gasper, D.O
Allopathic & Osteopathic Physicians|Family Medicine · VALPARAISO, IN · NPI 1770748717
Verified facts
What the public records show
CMS Open Payments records show Derek Scott Gasper, D.O received $250.00 in general payments during 2025 across 2 reported records.
HEARTFLOW, INC. accounted for 50.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 150 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| HEARTFLOW, INC. | Unresolved — no canonical attribution shown | $125.00 | 50.0% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $125.00 | 50.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $250.00 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FFRct Normalized: ffrct |
Device | HEARTFLOW, INC. | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $125.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 150 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
150 | 33 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1119 | 292 |
| Levothyroxine Sodium | Levothyroxine Sodium | 906 | 188 |
| Amlodipine Besylate | Amlodipine Besylate | 522 | 131 |
| Losartan Potassium | Losartan Potassium | 520 | 133 |
| Pantoprazole Sodium | Pantoprazole Sodium | 462 | 130 |
| Lisinopril | Lisinopril | 448 | 115 |
| Furosemide | Furosemide | 409 | 97 |
| Tamsulosin Hcl | Tamsulosin Hcl | 409 | 103 |
| Sertraline Hcl | Sertraline Hcl | 402 | 95 |
| Omeprazole | Omeprazole | 370 | 92 |
| Gabapentin | Gabapentin | 355 | 89 |
| Metformin Hcl | Metformin Hcl | 337 | 91 |
| Potassium Chloride | Potassium Chloride | 330 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 311 | 66 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 308 | 112 |
| Metoprolol Tartrate | Metoprolol Tartrate | 297 | 74 |
| Hydrochlorothiazide | Hydrochlorothiazide | 287 | 75 |
| Simvastatin | Simvastatin | 273 | 71 |
| Meloxicam | Meloxicam | 269 | 64 |
| Allopurinol | Allopurinol | 232 | 50 |
| Carvedilol | Carvedilol | 223 | 51 |
| Alprazolam | Alprazolam | 219 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 218 | 55 |
| Trazodone Hcl | Trazodone Hcl | 215 | 51 |
| Famotidine | Famotidine | 203 | 46 |
| Eliquis | Apixaban | 170 | 28 |
| Diclofenac Sodium | Diclofenac Sodium | 168 | 61 |
| Glimepiride | Glimepiride | 158 | 42 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 155 | 28 |
| Ozempic | Semaglutide | 150 | 33 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 150 | 44 |
| Bupropion Xl | Bupropion Hcl | 149 | 35 |
| Finasteride | Finasteride | 144 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 142 | 35 |
| Tramadol Hcl | Tramadol Hcl | 142 | 29 |
| Prednisone | Prednisone | 139 | 79 |
| Pregabalin | Pregabalin | 134 | 21 |
| Valsartan | Valsartan | 131 | 34 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 130 | 27 |
| Donepezil Hcl | Donepezil Hcl | 128 | 26 |
| Januvia | Sitagliptin Phosphate | 127 | 28 |
| Montelukast Sodium | Montelukast Sodium | 120 | 34 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 119 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 28 |
| Doxycycline Hyclate | Doxycycline Hyclate | 108 | 80 |
| Atenolol | Atenolol | 104 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 103 | 26 |
| Lorazepam | Lorazepam | 103 | 19 |
| Xarelto | Rivaroxaban | 103 | 15 |
| Methylprednisolone | Methylprednisolone | 99 | 86 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 98 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 98 | 22 |
| Ipratropium Bromide | Ipratropium Bromide | 96 | 39 |
| Mirtazapine | Mirtazapine | 95 | 21 |
| Spironolactone | Spironolactone | 95 | 27 |
| Synthroid | Levothyroxine Sodium | 91 | 21 |
| Warfarin Sodium | Warfarin Sodium | 91 | 13 |
| Memantine Hcl | Memantine Hcl | 88 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 88 | 22 |
| Clonazepam | Clonazepam | 87 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 84 | 34 |
| Telmisartan | Telmisartan | 83 | 20 |
| Glipizide | Glipizide | 82 | 24 |
| Nystatin | Nystatin | 78 | 37 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 78 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 77 | 21 |
| Breo Ellipta | Fluticasone/Vilanterol | 75 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 75 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 75 | 20 |
| Propranolol Hcl Er | Propranolol Hcl | 74 | 12 |
| Levetiracetam | Levetiracetam | 73 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 72 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 69 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 68 | 22 |
| Mounjaro | Tirzepatide | 68 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 65 | 19 |
| Cephalexin | Cephalexin | 64 | 39 |
| Bupropion Hcl Sr | Bupropion Hcl | 62 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 59 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 59 | 13 |
| Glipizide Er | Glipizide | 59 | 15 |
| Ezetimibe | Ezetimibe | 58 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 58 | 15 |
| Tradjenta | Linagliptin | 58 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 55 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 55 | 13 |
| Buspirone Hcl | Buspirone Hcl | 54 | suppressed |
| Chlorthalidone | Chlorthalidone | 54 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 54 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 37 |
| Metolazone | Metolazone | 52 | 18 |
| Enalapril Maleate | Enalapril Maleate | 50 | 12 |
| Glyburide | Glyburide | 50 | 18 |
| Jardiance | Empagliflozin | 50 | 12 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 49 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 47 | 13 |
| Primidone | Primidone | 47 | 13 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 47 | 14 |
| Diazepam | Diazepam | 46 | 11 |
| Fenofibrate | Fenofibrate | 46 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 46 | 14 |
| Humalog | Insulin Lispro | 45 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 45 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 44 | 35 |
| Metformin Hcl Er | Metformin Hcl | 44 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 42 | 32 |
| Alendronate Sodium | Alendronate Sodium | 40 | suppressed |
| Baclofen | Baclofen | 40 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 39 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 15 |
| Celecoxib | Celecoxib | 36 | suppressed |
| Novolog Flexpen | Insulin Aspart | 36 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 34 | suppressed |
| Sucralfate | Sucralfate | 34 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 33 | 12 |
| Colchicine | Colchicine | 30 | 15 |
| Liothyronine Sodium | Liothyronine Sodium | 30 | suppressed |
| Azithromycin | Azithromycin | 29 | 24 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 29 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 29 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 28 | suppressed |
| Bumetanide | Bumetanide | 28 | suppressed |
| Entresto | Sacubitril/Valsartan | 28 | suppressed |
| Irbesartan | Irbesartan | 28 | suppressed |
| Lacosamide | Lacosamide | 28 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 28 | suppressed |
| Topiramate | Topiramate | 28 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | 14 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Ketoconazole | Ketoconazole | 26 | 18 |
| Klor-Con M20 | Potassium Chloride | 26 | 12 |
| Methenamine Hippurate | Methenamine Hippurate | 26 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 26 | suppressed |
| Temazepam | Temazepam | 26 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 25 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Fluconazole | Fluconazole | 24 | 18 |
| Ibuprofen | Ibuprofen | 24 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 19 |
| Meclizine Hcl | Meclizine Hcl | 23 | 14 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | 11 |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Sotalol | Sotalol Hcl | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Mupirocin | Mupirocin | 20 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 19 | suppressed |
| Naproxen | Naproxen | 19 | suppressed |
| Nifedipine Er | Nifedipine | 19 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 18 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Cyclosporine | Cyclosporine | 15 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 15 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 15 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | suppressed |
| Cefdinir | Cefdinir | 14 | 13 |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 14 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | 12 |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 13 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Estazolam | Estazolam | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $250.00 · 2 records | HEARTFLOW, INC. | FFRct, Ozempic | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error